PD-1 vs PD-L1 Inhibitors: Do Outcomes Differ?

]]>(MedPage Today) -- Overall survival (OS) as well as progression-free survival (PFS) were superior when immune checkpoint inhibitors of the programmed cell death 1 (PD-1) apoptosis factor were used in cancer patients compared with programmed cell...